Expression of KITENIN and its association with tumor progression in oral squamous cell carcinoma

Auris Nasus Larynx

Volumn 40, Issue 2, 2013, Pages 222-226

  Yoon, Tae Mi ^a   Kim, Sun Ae ^a   Lee, Joon Kyoo ^a   Park, Young Lan ^a   Kim, Gyu Yeol ^a   Joo, Young Eun ^a   Lee, Jae Hyuk ^a   Kim, Kyung Keun ^a   Lim, Sang Chul ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

KITENIN; Molecular targeted therapy; Neoplasm metastasis; Oral cancer

Indexed keywords

KAI1 COOH-TERMINAL INTERACTING TETRASPANIN; SMALL INTERFERING RNA; TETRASPANIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KITENIN GENE; METASTASIS POTENTIAL; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CYTOLOGICAL TECHNIQUES; DISEASE PROGRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS;

EID: 84875382062     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2012.07.006     Document Type: Article

References (21)

1. Rinker-Schaeffer C.W., Hawkins A.L., Ru N., Dong J., Stoica G., Griffin C.A., et al. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 1994, 54:6249-6256.
2. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., Vukanovic J., Ichikawa T., Isaacs J.T., et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995, 268:884-886.
3. Dong J.T., Suzuki H., Pin S.S., Bovam S., Schalken J.A., Isaacs W.B., et al. Down-regulation of the KAI1 metastasis gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 1996, 56:4387-4390.
4. Adachi M., Taki T., Ieki Y., Huang C.L., Higashiyama M., Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996, 56:1751-1755.
5. Schindl M., Birner P., Breitenecker G., Oberhuber G. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Gynecol Oncol 2001, 83:244-248.
6. Su J.S., Arima K., Hasegawa M., Franco Oo, Umeda Y., Yanagawa M., et al. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma. Int J Urol 2004, 11:74-82.
7. Huang C.I., Kohno N., ogawa E., Adachi M., Taki T., Miyake M. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 1998, 153:973-983.
8. Lee H.S., Lee H.K., Kim H.S., Yang H.K., Kim W.H. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003, 200:39-46.
9. Kim J.H., Kim M.A., Lee H.S., Kim W.H. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas. Hum Pathol 2009, 40:314-322.
10. Liu W.M., Zhang X.A. KAI1/CD82, a tumor metastasis suppressor. Cancer Lett 2006, 240:183-194.
11. Jackson P., Marreiors A., Russell P.J. KAI1 tetraspanin and metastasis suppressor. Int J Biochem Cell Biol 2005, 37:530-534.
12. Miranti C.K. Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis. Cell Signal 2009, 21:196-211.
13. Lee J.H., Seo Y.W., Park S.R., Kim Y.J., Kim K.K. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res 2003, 63:7247-7255.
14. Lee J.H., Park S.R., Chay K.O., Seo Y.W., Kook H., Ahn K.Y., et al. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 2004, 64:4235-4243.
15. Yagyu R., Hamamoto R., Furukawa Y., Okabe H., Yamamura T., Nakamura Y. Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. Int J Oncol 2002, 20:1173-1178.
16. Lee J.H., Cho E.S., Kim M.Y., Seo Y.W., Kho D.H., Chung I.J., et al. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein. Cancer Res 2005, 65:8993-9003.
17. Kho D.H., Bae J.A., Lee J.H., Cho H.J., Cho S.H., Lee J.H., et al. KITENIN recruits Dishevelled/PKC delta to form a functional complex and controls the migration and invasiveness of colorectal cancer cells. Gut 2009, 58:509-519.
18. Rowe A., Jackson P. Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: relationship to KAI1/CD82 levels and invasive behaviour. Oncol Rep 2006, 16:1267-1272.
19. Lee J.K., Bae J.A., Sun E.G., Kim H.D., Yoon T.M., Kim K., et al. KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model. FEBS Lett 2009, 583:711-717.
20. Lee J.K., Yoon T.M., Seo D.J., Sun E.G., Bae J.A., Lim S.C., et al. KAI1 COOH-terminal interacting tetraspanin (KITENIN) expression in early and advanced laryngeal cancer. Laryngoscope 2010, 120:953-958.
21. Lee J.K., Lim S.C., Kim H.D., Yoon T.M., Kim K., Nam J.H., et al. KITENIN represents a more aggressive phenotype in a murine model of oral cavity squamous carcinoma. Otolaryngol Head Neck Surg 2010, 142:747-752.